BioCentury
ARTICLE | Finance

Buying local

How CanSino's $65M round could help its first three vaccines reach China market

April 22, 2017 12:00 AM UTC

CanSino Biologics Inc.’s investors are hoping a $65 million venture round will be enough to help the company launch a trio of products by 2019 to tap China’s growing demand for vaccines.

Future Industry Investment Fund, which is managed by the SDIC Fund Management Co. Ltd. subsidiary of State Development & Investment Corp., led last week’s round with participation from fellow new investors Gopher Asset Management, Fortune Capital and Goldstone Investment and existing investors Lilly Asia Ventures and Qiming Venture Partners. ...

BCIQ Company Profiles

CanSino Biologics Inc.